Government oversight of genetic engineering in the U.S. is on the verge of shifting its concerns from safety in experimentation to areas such as gene therapy and other uses that affect humans directly. To the relief of industrial observers, this oversight will probably focus on clinical applications rather than the manufacturing of substances. Few similiar signs are apparent elsewhere, but other countries are keeping an eye on U.S. developments. Around the world, the trend toward relaxation of regulation continues.
Rights and permissions
About this article
Cite this article
Powledge, T. Surveillance of Genetic Engineering: Will Restraints continue to Loosen?. Nat Biotechnol 1, 322–328 (1983). https://doi.org/10.1038/nbt0683-322
Issue Date:
DOI: https://doi.org/10.1038/nbt0683-322
- Springer Nature America, Inc.
This article is cited by
-
Applications
Environmental Management (1986)